Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oragenics Inc
(NY:
OGEN
)
0.2920
-0.0120 (-3.95%)
Official Closing Price
Updated: 8:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Oragenics Inc
< Previous
1
2
3
4
Next >
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
November 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 14, 2024
Via
Benzinga
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate
October 08, 2024
Oragenics completed a key study showing its nasal spray drug ONP-002 effectively targets brain-related nasal areas, setting the stage for Phase 2 trials in concussion treatment.
Via
Benzinga
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
October 08, 2024
Via
Benzinga
Why Oragenics (OGEN) Stock Is Getting Hammered
September 04, 2024
Oragenics shares are trading lower by 47% during Wednesday's session. The company announced a $4.45 million public offering.
Via
Benzinga
OGEN Stock Earnings: Oragenics Reported Results for Q2 2024
August 12, 2024
Oragenics just reported results for the second quarter of 2024.
Via
InvestorPlace
OGEN Stock Earnings: Oragenics Reported Results for Q4 2023
June 28, 2024
Oragenics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 25, 2024
Via
Benzinga
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings
September 04, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Mixed; Trade Gap Widens In July
September 04, 2024
Via
Benzinga
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
September 04, 2024
Via
Benzinga
Why Oragenics (OGEN) Shares Are Falling
June 25, 2024
Oragenics shares are trading lower by 21% during Tuesday's session. The company announced pricing of its public offering.
Via
Benzinga
OGEN Stock Earnings: Oragenics Reported Results for Q1 2024
May 15, 2024
Oragenics just reported results for the first quarter of 2024.
Via
InvestorPlace
EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury
August 21, 2024
Oragenics completes the formulation and filling of its nasal spray drug, ONP-002, for concussion treatment, aiming to launch a Phase 2a trial.
Via
Benzinga
EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway
August 08, 2024
Oragenics announced its lead candidate, ONP-002, for treating concussion, which shows no cardiotoxicity in studies. Designed for nasal delivery to the brain, ONP-002 aims to address the significant...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 05, 2024
Via
Benzinga
Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
May 22, 2024
Via
Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 22, 2024
Via
Benzinga
Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings
May 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 07, 2024
Via
Benzinga
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
February 28, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 28, 2024
Via
Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
February 28, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Dips 200 Points; TJX Posts Upbeat Sales
February 28, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.